| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/17/2005 | US20050059602 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 03/17/2005 | US20050059601 by administering an exendin peptide analog of given amino acid sequence; treating Type II diabetes, eating disorders, and insulin-resistance syndrome |
| 03/17/2005 | US20050059600 Chimeric natriuretic peptides |
| 03/17/2005 | US20050059599 Elastin peptide analogs and uses thereof |
| 03/17/2005 | US20050059598 Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency |
| 03/17/2005 | US20050059597 Method of reducing injury to mammalian cells |
| 03/17/2005 | US20050059596 Modulating response to genotoxic stress |
| 03/17/2005 | US20050059595 Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions |
| 03/17/2005 | US20050059594 Administering macrophage derived factor; oncomodulin |
| 03/17/2005 | US20050059593 From Vibrio cholerae phage; cadherins; immunogens; drug screening; for treatment of autoimmune and gastrointestinal diseases, food allergies, and Celiac disease; vaccines; antibodies |
| 03/17/2005 | US20050059591 Prevention and treatment of amyloidogenic disease |
| 03/17/2005 | US20050059590 Modified IL-4 mutein receptor antagonists |
| 03/17/2005 | US20050059589 Such as cutaneous, ocular, nasal and bronchial allergic disease; interleukins and tumor necrosis factor receptors; competitive binding |
| 03/17/2005 | US20050059588 Human anion exchange protein; antigen presenting cells; for treatment of diabetes, thalassemia, sickle cell anemia, and falciparum malaria |
| 03/17/2005 | US20050059587 Use of a protein for the production of a medicament for stimulating the innate non-specific immune system |
| 03/17/2005 | US20050059586 For increasing expression of human presenilin; for treatment of neurodegenerative diseases, Alzheimer's disease; drug screening |
| 03/17/2005 | US20050059585 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 03/17/2005 | US20050059584 Stroma cell-derived factor (SDF-1) and/or SDF-1/macrophage inflammatory protein (MIP1) alpha hybrid analogs; for increasing hemocrit, mobilizing stem cells, vaccine production, or gene therapy; for mobilizing intracellular calcium and leukocytes |
| 03/17/2005 | US20050059583 For treating dry eyes; conjunctivitis |
| 03/17/2005 | US20050059582 For treating systemic hemorrhagic conditions, stabilizing blood pressure, and protecting hypoxic/ischemic tissues; thrombosis |
| 03/17/2005 | US20050059581 Endometrial/epithelial cancer; peroxisome proliferator-activated receptor gamma agonists such as pioglitazone and rosiglitazone |
| 03/17/2005 | US20050059580 Biglycan and related therapeutics and methods of use |
| 03/17/2005 | US20050059579 Dietary and pharmaceutical compositions for management and treatment of oxidative stress |
| 03/17/2005 | US20050059577 Glycosylphosphatidylinositol containing polypeptides |
| 03/17/2005 | US20050059574 Compositions of stable T3 and methodes of use thereof |
| 03/17/2005 | US20050059149 Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins |
| 03/17/2005 | US20050059144 MHC class II antigen-presenting systems and methods for activating CD4+ T cells |
| 03/17/2005 | US20050059132 Variant blood coagulation factor for use as tool in treatment of thrombosis |
| 03/17/2005 | US20050059126 Engineered enzymes comprised of protein scaffold and specificity determining regions; fusion proteins, nucleic acid molecules, vectors, host cells |
| 03/17/2005 | US20050059120 Using allergen induced cytokines as tool in diagnosing inflammatory bowel disease |
| 03/17/2005 | US20050059118 Hyaluronan receptor for endocytosis |
| 03/17/2005 | US20050059116 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents |
| 03/17/2005 | US20050059115 Using biglycan protein to diagnose, prevent and treatment of cell proliferative disorders |
| 03/17/2005 | US20050059114 Expression vector comprising nucleotide sequences coding platelet activating factor receptor (PAF) for use in identifying modulator for prevention and treatment of nervous ssytem, bone, hypotensive, heart and urogenital disorders |
| 03/17/2005 | US20050059110 Human nervous system-associated proteins |
| 03/17/2005 | US20050059109 Methods and compositions for polypeptide engineering |
| 03/17/2005 | US20050059108 Expression vector comprising nucleotide sequences coding neurotransmitter for use in prevention and treatment of obesity, anorexia, energy imbalance, diabetes, dyslipidemia, hypertension and/or insulin resistance |
| 03/17/2005 | US20050059099 PSCA: prostate stem cell antigen and uses thereof |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | US20050059079 Expression vector comprising nucleotide sequences associated with neuropsychological disruption for use in diagnosis, prevention and treatment of schizophrenia, mood and bipolar disorders |
| 03/17/2005 | US20050059073 Expression vector comprising nucleotide sequences coding cell growth factors for use in treatment and prevention of nervous system disorders |
| 03/17/2005 | US20050059051 Expression vector comprising nucleotide sequences coding transmembrane protein for use as tool in stimulating lymphocyte response and treatment and prevention of inflammatory and autoimmune diseases |
| 03/17/2005 | US20050059050 Novel human ion-exchanger proteins and polynucleotides encoding the same |
| 03/17/2005 | US20050059040 Guidance receptor protein for use as tool in identifying modlator for use in treatment and preventio of nervous system disorders |
| 03/17/2005 | US20050059008 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 03/17/2005 | US20050059005 Microrna molecules |
| 03/17/2005 | US20050059002 Novel serine protease |
| 03/17/2005 | US20050058999 Gene involved in apoptosis regulation |
| 03/17/2005 | US20050058998 Amino acid and nucleic acid sequences of cyclic nucleotide phosphodiesterases that are involved in T cell activation and may be used in the diagnosis and treatment of disorders such as autoimmune diseases |
| 03/17/2005 | US20050058993 Method and device for detecting feline immunodeficiency virus |
| 03/17/2005 | US20050058992 Method and device for detecting feline immunodeficiency virus |
| 03/17/2005 | US20050058982 Modified small interfering RNA molecules and methods of use |
| 03/17/2005 | US20050058767 Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities |
| 03/17/2005 | US20050058702 Compositions capable of facilitating penetration across a biological barrier |
| 03/17/2005 | US20050058691 Controlling the amount of iodine a cat eats to restore norman thyroid function |
| 03/17/2005 | US20050058666 Method for treating pain by peripheral administration of a neuroptoxin |
| 03/17/2005 | US20050058660 Novel surface antigen |
| 03/17/2005 | US20050058659 Forming fusion peptides with 14 to 75 amino acids in prokaryotic host cell and encoding fusion peptide for expression vectors |
| 03/17/2005 | US20050058657 Vaccines for treatment of Aids |
| 03/17/2005 | US20050058654 For therapy of cancers, autoimmune diseases, immunodeficiency diseases, reperfusion injuries, and neurodegenerative diseases |
| 03/17/2005 | US20050058653 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
| 03/17/2005 | US20050058651 Compositions and methods to prevent metastasis from primary malignancies |
| 03/17/2005 | US20050058647 Newly identified polypeptide and polynucleotides for diagnosis of new compounds |
| 03/17/2005 | US20050058646 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyalurons |
| 03/17/2005 | US20050058644 Compounds for treatment of cancer using lymphocytes, monoclonal antibodies and interferons |
| 03/17/2005 | US20050058643 Binding to major histocompatibility complex; immunosuppression; therapy, prevention multiple sclerosis |
| 03/17/2005 | US20050058641 Tolerance induction and maintenance in hematopoietic stem cell allografts |
| 03/17/2005 | US20050058637 Therapy, prevention of viral infections; obtaining viron sample; incubation, monitoring, calibration: using antithrombin agent |
| 03/17/2005 | US20050058636 Medicament against thrombotic diseases |
| 03/17/2005 | US20050058627 TTK in diagnosis and as a therapeutic target in cancer |
| 03/17/2005 | US20050058624 Fusion proteins; adjust half-life; septic shock, diabetes, antiinflammatory agents |
| 03/17/2005 | US20050058623 Use of gp130 activators in diabetic neuropathy |
| 03/17/2005 | US20050058599 Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent |
| 03/17/2005 | DE10339820A1 Use of G-protein coupled receptor, GPR49, peptides, protein and nucleic acid, for diagnosis and prognosis of tumors, also in screening for therapeutic and diagnostic agents |
| 03/17/2005 | DE10337074A1 Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention von chronischen neurodegenerativen Erkrankungen Use of inhibitors of enzymes with activities of aminopeptidase N and / or of dipeptidyl peptidase IV and pharmaceutical preparations thereof for the treatment and prevention of chronic neurodegenerative diseases |
| 03/17/2005 | CA2579635A1 Peptides that inhibit complement activation |
| 03/17/2005 | CA2540198A1 Tick engorgement factor proteins |
| 03/17/2005 | CA2537878A1 Polymorphic nucleoside compounds |
| 03/17/2005 | CA2537844A1 Treatment of neurodegenerative diseases |
| 03/17/2005 | CA2537798A1 Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof |
| 03/17/2005 | CA2537765A1 Methods and compositions for the prevention and treatment of genitourinary disorders, including pre-term labor and leiomyomas |
| 03/17/2005 | CA2537763A1 Treatment for cd5+ b cell lymphoma |
| 03/17/2005 | CA2537290A1 Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
| 03/17/2005 | CA2537273A1 Method for the production of fusion proteins in transgenic mammal milk |
| 03/17/2005 | CA2537246A1 Skin ulcer preventive or curative agent containing human recombinant hgf |
| 03/17/2005 | CA2537145A1 Co-expression vector for the membrane domains of virus envelope proteins and uses thereof |
| 03/17/2005 | CA2537128A1 New antitumoral compounds |
| 03/17/2005 | CA2537096A1 Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an lhrh analogue and/or a bisphosphonate |
| 03/17/2005 | CA2536669A1 Methods for intradermal delivery of therapeutics agents |
| 03/17/2005 | CA2536586A1 Modified il-4 mutein receptor antagonists |
| 03/17/2005 | CA2536512A1 Rage-related methods and compositions for treating glomerular injury |
| 03/17/2005 | CA2535021A1 Use of insp035 to treat fibrotic disease |
| 03/17/2005 | CA2534907A1 Homogeneous preparations of il-28 and il-29 |
| 03/17/2005 | CA2534886A1 A method selecting an immunotherapeutic preparation |
| 03/17/2005 | CA2526428A1 Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections |
| 03/17/2005 | CA2517264A1 Ebola peptides and immunogenic compositions containing same |
| 03/16/2005 | EP1514929A1 Antisense oligonucleotides for prevention of metastasis formation of cancer cells |
| 03/16/2005 | EP1514928A1 Method of constructing antibody |
| 03/16/2005 | EP1514877A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process |
| 03/16/2005 | EP1514876A2 Antibody against prostate stem cell antigen (PSCA) |